---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-032830"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2026-07-10T20:01:30+00:00"
generated_at: "2026-07-10T20:03:15.709019+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ENvue Medical receives Nasdaq delisting notice for bid price non-compliance

## Summary
- Closing bid price below $1.00 for 30 consecutive business days (May 26–July 8, 2026).
- Ineligible for 180-day cure period due to reverse stock split (1-for-10) on Aug 12, 2025.
- Company will request a hearing before Nasdaq Panel to appeal the determination.
- No assurance that continued listing will be granted or compliance regained.

## SEC filing metadata
- accession: 0001493152-26-032830
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2026-07-10T20:01:30+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315226032830/0001493152-26-032830-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315226032830/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-032830
- JSON: https://secwatch.observer/filing/0001493152-26-032830.json
- Plain text: https://secwatch.observer/filing/0001493152-26-032830.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.